Posted on

Common Adverse Events with Single-Agent or Combination Therapy

Common Adverse Events with Single-Agent or Combination Therapy

Metastatic Renal Cell Carcinoma: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management – Episode 18

Mehmet Asim Bilen, MD, provides an overview of commonly observed adverse events in patients with metastatic RCC receiving single-agent or combination therapy.